Other languages Palisade Bio, Inc.

Equities

SNCA

US6963894026

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
5.07 ^USD	-23.18%		+15.75%	-42.71%

Apr. 16	Sector Update: Health Care Stocks Edge Up Tuesday Afternoon	MT
Apr. 16	Palisade Bio Shows Bioactivation of PALI-2108 in Study; Shares Rise	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients? Stool	Apr. 16
Palisade Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26
Palisade Bio, Inc. Announces Resignation of Mary Ann Gray as Member of the Board	Mar. 06
Palisade Bio Names Donald Williams as Chairman	Feb. 13
Palisade Bio, Inc. Announces Advisory Board Appointments	Feb. 08
MÄRKTE USA/Fester - Neue Rekordhochs dank sinkender Anleihezinsen	Jan. 29
Sector Update: Health Care Stocks Stronger Late Afternoon	Jan. 29
Sector Update: Health Care Stocks Advance Monday Afternoon	Jan. 29
Top Midday Gainers	Jan. 29
Palisade Bio's Shares Climb Following Preclinical Data on Ulcerative Colitis Drug Candidate	Jan. 29
LATE BRIEFING - Unternehmen und Märkte	Jan. 29
MÄRKTE USA/Kaum verändert - Vor Fed-Entscheid dominiert Zurückhaltung	Jan. 29
MÄRKTE USA/Wall Street startet wenig verändert in Fed-Woche	Jan. 29
MÄRKTE USA/Wall Street wenig verändert erwartet	Jan. 29
MORNING BRIEFING - USA/Asien	Jan. 29
Palisade Bio Says Giiant Pharma Receives Second Milestone Payment for PALI-2108 Development	Dec. 28
Palisade Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Palisade Bio, Inc. Announces the Appointment of Mitchell Jones, M.D., Ph.D., as Chief Medical Officer	23-09-11
Palisade Bio, Inc. Appoints Mitchell Jones as Chief Medical Officer	23-09-11
Sector Update: Health Care Stocks Advancing Late Thursday Afternoon	23-09-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Palisade Bio, Inc.

Equities

SNCA

US6963894026

Other languages

Filters